The potential impact of COVID-19-related disruption on tuberculosis burden

Before the coronavirus disease 2019 (COVID-19) pandemic, over 4000 people were dying from tuberculosis (TB) every day [1]. As with past emergencies [2], the impact of COVID-19 on TB outcomes is a serious cause for concern [3] but is currently unknown. Health system overload, due to high numbers of C...

Full description

Saved in:
Bibliographic Details
Published inThe European respiratory journal Vol. 56; no. 2; p. 2001718
Main Authors McQuaid, C. Finn, McCreesh, Nicky, Read, Jonathan M., Sumner, Tom, Houben, Rein M.G.J., White, Richard G., Harris, Rebecca C.
Format Journal Article
LanguageEnglish
Published England European Respiratory Society 01.08.2020
Subjects
Online AccessGet full text
ISSN0903-1936
1399-3003
1399-3003
DOI10.1183/13993003.01718-2020

Cover

Abstract Before the coronavirus disease 2019 (COVID-19) pandemic, over 4000 people were dying from tuberculosis (TB) every day [1]. As with past emergencies [2], the impact of COVID-19 on TB outcomes is a serious cause for concern [3] but is currently unknown. Health system overload, due to high numbers of COVID-19 cases, as well as interventions necessary to limit the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), could result in severe reductions in health service availability and access for the detection and treatment of TB cases [4]. However, physical distancing interventions could also limit Mycobacterium tuberculosis transmission outside of households, where most transmission occurs [5]. This has not been adequately explored in concurrent work [6–8], and it is currently unclear whether social distancing could compensate for disruptions in TB services, and what the impact of these combined COVID-19 disruption effects on TB burden is likely to be. Any benefit of social distancing on TB deaths is likely to be outweighed by health service disruption. As such, it is crucially important to maintain and strengthen TB-related health services during, and after, the COVID-19 pandemic. https://bit.ly/30aWZnp
AbstractList Before the coronavirus disease 2019 (COVID-19) pandemic, over 4000 people were dying from tuberculosis (TB) every day [1]. As with past emergencies [2], the impact of COVID-19 on TB outcomes is a serious cause for concern [3] but is currently unknown. Health system overload, due to high numbers of COVID-19 cases, as well as interventions necessary to limit the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), could result in severe reductions in health service availability and access for the detection and treatment of TB cases [4]. However, physical distancing interventions could also limit Mycobacterium tuberculosis transmission outside of households, where most transmission occurs [5]. This has not been adequately explored in concurrent work [6–8], and it is currently unclear whether social distancing could compensate for disruptions in TB services, and what the impact of these combined COVID-19 disruption effects on TB burden is likely to be. Any benefit of social distancing on TB deaths is likely to be outweighed by health service disruption. As such, it is crucially important to maintain and strengthen TB-related health services during, and after, the COVID-19 pandemic. https://bit.ly/30aWZnp
Author McQuaid, C. Finn
Houben, Rein M.G.J.
White, Richard G.
McCreesh, Nicky
Harris, Rebecca C.
Read, Jonathan M.
Sumner, Tom
AuthorAffiliation 4 A list of members of the CMMID COVID-19 Working Group can be found in the acknowledgements section
2 Center for Health Informatics Computing and Statistics, Lancaster Medical School, Lancaster University, Lancaster, UK
1 TB Modelling Group, TB Centre, and Centre for Mathematical Modelling of Infectious Diseases, Dept of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK
3 Sanofi Pasteur, Singapore
AuthorAffiliation_xml – name: 2 Center for Health Informatics Computing and Statistics, Lancaster Medical School, Lancaster University, Lancaster, UK
– name: 1 TB Modelling Group, TB Centre, and Centre for Mathematical Modelling of Infectious Diseases, Dept of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK
– name: 3 Sanofi Pasteur, Singapore
– name: 4 A list of members of the CMMID COVID-19 Working Group can be found in the acknowledgements section
Author_xml – sequence: 1
  givenname: C. Finn
  surname: McQuaid
  fullname: McQuaid, C. Finn
– sequence: 2
  givenname: Nicky
  surname: McCreesh
  fullname: McCreesh, Nicky
– sequence: 3
  givenname: Jonathan M.
  surname: Read
  fullname: Read, Jonathan M.
– sequence: 4
  givenname: Tom
  surname: Sumner
  fullname: Sumner, Tom
– sequence: 5
  givenname: Rein M.G.J.
  orcidid: 0000-0003-4132-7467
  surname: Houben
  fullname: Houben, Rein M.G.J.
– sequence: 6
  givenname: Richard G.
  surname: White
  fullname: White, Richard G.
– sequence: 7
  givenname: Rebecca C.
  surname: Harris
  fullname: Harris, Rebecca C.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32513784$$D View this record in MEDLINE/PubMed
BookMark eNp9UUtLxDAQDqLo-vgFgvTopZo0bZJeBFnfCHtZvYY0mWqk29QkFfz3pr5QD8LAwMz3GObbRuu96wGhfYKPCBH0mNC6phjTI0w4EXmBC7yGZtM0n8braIZrTHNSU7aFtkN4wpiwkpJNtEWLilAuyhm6WT5CNrgIfbSqy-xqUDpmrs3mi_vrs0TOPXQqgsmMDX4conV9liqODXg9di7YkDWjN9Dvoo1WdQH2PvsOurs4X86v8tvF5fX89DbXVVXFXGiuONW8ZaoqedOoUlAMnLHSmJYbwTA3LQMBreZl3UJRg2FFw4XWdVESSnfQyYfuMDYrMDqd7lUnB29Xyr9Kp6z8vento3xwL5IXXFS4TAKHnwLePY8QolzZoKHrVA9uDDK5EIIZx1WCHvz0-jb5emAC0A-A9i4ED-03hGA5xSS_YpLvMckppsSq_7C0jWr6bTrYdv9y3wDiupbF
CitedBy_id crossref_primary_10_1093_cid_ciac455
crossref_primary_10_3390_medsci11040063
crossref_primary_10_3390_microorganisms9061158
crossref_primary_10_1136_bmjopen_2023_071799
crossref_primary_10_1136_thorax_2023_220047
crossref_primary_10_1371_journal_pgph_0003043
crossref_primary_10_3390_life12101468
crossref_primary_10_1080_23744235_2020_1806353
crossref_primary_10_3390_hygiene3010001
crossref_primary_10_1080_07853890_2022_2160491
crossref_primary_10_1371_journal_pgph_0000219
crossref_primary_10_1016_j_jeph_2024_202795
crossref_primary_10_1017_dmp_2022_142
crossref_primary_10_2807_1560_7917_ES_2021_26_24_2100231
crossref_primary_10_3389_ftubr_2024_1438406
crossref_primary_10_1146_annurev_economics_051520_025412
crossref_primary_10_1111_joim_13197
crossref_primary_10_1186_s12913_021_06852_z
crossref_primary_10_1016_j_jctube_2020_100199
crossref_primary_10_1016_j_arbres_2021_05_035
crossref_primary_10_1183_13993003_03890_2020
crossref_primary_10_1111_1462_2920_15217
crossref_primary_10_1007_s12038_025_00496_5
crossref_primary_10_3346_jkms_2020_35_e388
crossref_primary_10_1038_s44259_024_00066_z
crossref_primary_10_4103_ijmr_IJMR_326_21
crossref_primary_10_1108_IJOPH_09_2020_0067
crossref_primary_10_5812_jjm_134575
crossref_primary_10_34215_1609_1175_2022_4_43_48
crossref_primary_10_1007_s00431_023_04981_7
crossref_primary_10_3346_jkms_2023_38_e43
crossref_primary_10_3389_fcimb_2022_929689
crossref_primary_10_3389_fimmu_2021_641378
crossref_primary_10_3390_biom13020248
crossref_primary_10_1016_j_regg_2021_04_007
crossref_primary_10_1016_j_ijregi_2022_12_008
crossref_primary_10_1016_S2214_109X_23_00312_1
crossref_primary_10_3390_polym14132577
crossref_primary_10_9745_GHSP_D_21_00368
crossref_primary_10_1016_S1473_3099_24_00007_0
crossref_primary_10_1038_s41598_022_18135_6
crossref_primary_10_1016_j_arbres_2020_11_016
crossref_primary_10_3390_antibiotics10060693
crossref_primary_10_1007_s11356_022_22849_5
crossref_primary_10_1159_000516509
crossref_primary_10_3389_fpubh_2021_644536
crossref_primary_10_1038_d41586_020_02334_0
crossref_primary_10_1055_a_1351_9176
crossref_primary_10_2147_IDR_S428652
crossref_primary_10_7759_cureus_60412
crossref_primary_10_1080_14740338_2023_2205638
crossref_primary_10_3390_antibiotics11111622
crossref_primary_10_3389_fmed_2022_971008
crossref_primary_10_3390_pathogens13060491
crossref_primary_10_12688_f1000research_28318_1
crossref_primary_10_22270_jddt_v14i12_6915
crossref_primary_10_12688_f1000research_28318_2
crossref_primary_10_1016_S2213_2600_21_00020_5
crossref_primary_10_1186_s12889_021_12142_4
crossref_primary_10_1016_j_epidem_2022_100540
crossref_primary_10_1038_s41579_022_00731_y
crossref_primary_10_1186_s43168_022_00117_x
crossref_primary_10_1016_S0140_6736_20_32138_3
crossref_primary_10_2478_amtsb_2021_0025
crossref_primary_10_1016_j_mmifmc_2022_03_338
crossref_primary_10_3390_idr17010011
crossref_primary_10_3389_fpubh_2022_937844
crossref_primary_10_1038_s41591_022_01750_1
crossref_primary_10_1016_j_ijid_2021_08_055
crossref_primary_10_1177_2333794X231156048
crossref_primary_10_1183_13993003_02538_2021
crossref_primary_10_1016_j_actatropica_2022_106776
crossref_primary_10_1093_trstmh_traa067
crossref_primary_10_1186_s40249_024_01188_2
crossref_primary_10_1016_j_jiac_2021_06_021
crossref_primary_10_1016_S2213_2600_20_30392_1
crossref_primary_10_24171_j_phrp_2021_0063
crossref_primary_10_1016_j_jiac_2023_09_018
crossref_primary_10_12688_f1000research_53385_1
crossref_primary_10_3390_vaccines9111228
crossref_primary_10_2807_1560_7917_ES_2021_26_24_2100426
crossref_primary_10_3390_tropicalmed7090247
crossref_primary_10_1371_journal_pmed_1003675
crossref_primary_10_1590_0102_311x00094520
crossref_primary_10_3390_ijms241612709
crossref_primary_10_2196_35994
crossref_primary_10_1080_17476348_2021_1924682
crossref_primary_10_2185_jrm_2021_039
crossref_primary_10_1016_j_lanwpc_2020_100032
crossref_primary_10_1016_j_lansea_2022_04_007
crossref_primary_10_1186_s12916_021_02063_9
crossref_primary_10_1016_j_ijtb_2021_07_014
crossref_primary_10_1016_j_ijtb_2024_11_005
crossref_primary_10_1016_S2214_109X_22_00414_4
crossref_primary_10_1038_s43856_022_00145_0
crossref_primary_10_1186_s13256_021_03193_7
crossref_primary_10_1186_s12879_024_10244_z
crossref_primary_10_1016_j_hjdsi_2020_100487
crossref_primary_10_1186_s13063_021_05331_4
crossref_primary_10_1183_13993003_02710_2020
crossref_primary_10_1136_bmjgh_2021_007456
crossref_primary_10_1371_journal_pone_0249822
crossref_primary_10_3390_antibiotics10030272
crossref_primary_10_1186_s13031_020_00325_6
crossref_primary_10_5588_ijtldopen_24_0194
crossref_primary_10_1183_16000617_0264_2021
crossref_primary_10_2196_29463
crossref_primary_10_1371_journal_pone_0291404
crossref_primary_10_1002_iid3_981
crossref_primary_10_1002_ardp_202300187
crossref_primary_10_1016_j_rmr_2020_09_006
crossref_primary_10_15252_emmm_202114088
crossref_primary_10_1007_s40475_021_00241_6
crossref_primary_10_2139_ssrn_4057232
crossref_primary_10_2174_1871526522666220407001744
crossref_primary_10_3389_fcimb_2021_624607
crossref_primary_10_1183_23120541_00507_2020
crossref_primary_10_1186_s12913_022_08855_w
crossref_primary_10_1016_S0140_6736_23_01379_X
crossref_primary_10_1186_s12916_022_02624_6
crossref_primary_10_1371_journal_pgph_0000150
crossref_primary_10_1016_j_eclinm_2020_100603
crossref_primary_10_1186_s12992_021_00666_8
crossref_primary_10_5205_1981_8963_2024_261495
crossref_primary_10_1371_journal_pone_0273389
crossref_primary_10_1038_s41467_023_37314_1
crossref_primary_10_1371_journal_pgph_0003309
crossref_primary_10_1016_j_jctube_2022_100335
crossref_primary_10_1186_s40981_021_00467_3
crossref_primary_10_15212_ZOONOSES_2021_0021
crossref_primary_10_3390_diagnostics11122221
crossref_primary_10_1016_j_tube_2020_102020
crossref_primary_10_1016_j_jiph_2021_07_001
crossref_primary_10_1016_j_pulmoe_2022_04_012
crossref_primary_10_26787_nydha_2686_6838_2022_24_4_64_69
crossref_primary_10_1007_s44197_023_00085_5
crossref_primary_10_1016_j_arbres_2021_05_014
crossref_primary_10_1136_bmjgh_2021_007878
crossref_primary_10_1371_journal_pone_0269458
crossref_primary_10_1016_j_lfs_2024_122778
crossref_primary_10_1016_S2213_2600_22_00092_3
crossref_primary_10_1186_s40249_024_01223_2
crossref_primary_10_1016_j_hsr_2023_100128
crossref_primary_10_1016_j_tube_2022_102202
crossref_primary_10_1371_journal_pgph_0001018
crossref_primary_10_3390_ijms23042235
crossref_primary_10_3390_diagnostics14070698
crossref_primary_10_3390_jpm13121629
crossref_primary_10_21292_2075_1230_2022_100_9_46_58
crossref_primary_10_1128_spectrum_00090_23
crossref_primary_10_4103_ijcfm_ijcfm_61_22
crossref_primary_10_3389_fmed_2022_905245
Cites_doi 10.3201/eid2203.150977
10.1183/13993003.01398-2020
10.1016/S2213-2600(20)30151-X
10.1101/2020.04.28.20079582
10.1101/2020.03.19.20039107
10.5588/ijtld.20.0127
10.1016/S2214-109X(18)30452-2
10.1016/j.pulmoe.2020.05.002
10.1371/journal.pone.0132840
ContentType Journal Article
Copyright Copyright ©ERS 2020. 2020
Copyright_xml – notice: Copyright ©ERS 2020. 2020
CorporateAuthor CMMID COVID-19 Working Group
CorporateAuthor_xml – name: CMMID COVID-19 Working Group
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1183/13993003.01718-2020
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Potential impact of COVID-19-related disruption on TB burden
EISSN 1399-3003
ExternalDocumentID PMC7278504
32513784
10_1183_13993003_01718_2020
Genre Letter
Review
Correspondence
GrantInformation_xml – fundername: Medical Research Council
  grantid: MR/P002404/1
– fundername: Medical Research Council
  grantid: MR/V038613/1
GroupedDBID ---
.55
.GJ
18M
1OC
2WC
31~
3O-
53G
5GY
5RE
5VS
8-1
AADJU
AAFWJ
AAYXX
AAZMJ
ABCQX
ABJNI
ABOCM
ABSQV
ACEMG
ACGFO
ACPRK
ACXQS
ADBBV
ADDZX
ADMOG
ADYFA
AENEX
AFFNX
AFHIN
AFZJQ
AIZTS
AJAOE
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BTFSW
CAG
CITATION
COF
CS3
DIK
E3Z
EBS
EJD
F5P
F9R
GX1
H13
INIJC
J5H
KQ8
L7B
LH4
LW6
OK1
P2P
PQQKQ
R0Z
RHI
TER
TR2
W8F
WOQ
X7M
ZE2
ZGI
ZXP
~02
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c555t-8c7a73c7f6a547bba4830e7664ddf7d8607df6e8efc749fe29ed62b78cc924133
ISSN 0903-1936
1399-3003
IngestDate Thu Aug 21 17:12:42 EDT 2025
Fri Sep 05 14:10:03 EDT 2025
Sat May 31 02:12:43 EDT 2025
Tue Aug 05 12:07:09 EDT 2025
Thu Apr 24 22:50:55 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
License This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c555t-8c7a73c7f6a547bba4830e7664ddf7d8607df6e8efc749fe29ed62b78cc924133
Notes SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
content type line 23
ObjectType-Review-2
ORCID 0000-0003-4132-7467
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC7278504
PMID 32513784
PQID 2411106705
PQPubID 23479
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7278504
proquest_miscellaneous_2411106705
pubmed_primary_32513784
crossref_primary_10_1183_13993003_01718_2020
crossref_citationtrail_10_1183_13993003_01718_2020
PublicationCentury 2000
PublicationDate 2020-08-01
PublicationDateYYYYMMDD 2020-08-01
PublicationDate_xml – month: 08
  year: 2020
  text: 2020-08-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle The European respiratory journal
PublicationTitleAlternate Eur Respir J
PublicationYear 2020
Publisher European Respiratory Society
Publisher_xml – name: European Respiratory Society
References 2024102101461492000_56.2.2001718.6
2024102101461492000_56.2.2001718.7
2024102101461492000_56.2.2001718.8
2024102101461492000_56.2.2001718.9
Pang (2024102101461492000_56.2.2001718.4) 2020; 24
2024102101461492000_56.2.2001718.15
2024102101461492000_56.2.2001718.2
2024102101461492000_56.2.2001718.1
Motta (2024102101461492000_56.2.2001718.16) 2020; 26
Glynn (2024102101461492000_56.2.2001718.5) 2015; 10
Wingfield (2024102101461492000_56.2.2001718.3) 2020; 8
2024102101461492000_56.2.2001718.10
Harris (2024102101461492000_56.2.2001718.13) 2019; 7
2024102101461492000_56.2.2001718.11
2024102101461492000_56.2.2001718.12
2024102101461492000_56.2.2001718.14
32703778 - Eur Respir J. 2020 Sep 24;56(3):2002710. doi: 10.1183/13993003.02710-2020.
References_xml – ident: 2024102101461492000_56.2.2001718.6
– ident: 2024102101461492000_56.2.2001718.8
– ident: 2024102101461492000_56.2.2001718.2
  doi: 10.3201/eid2203.150977
– ident: 2024102101461492000_56.2.2001718.14
– ident: 2024102101461492000_56.2.2001718.15
  doi: 10.1183/13993003.01398-2020
– ident: 2024102101461492000_56.2.2001718.1
– ident: 2024102101461492000_56.2.2001718.11
– ident: 2024102101461492000_56.2.2001718.12
– ident: 2024102101461492000_56.2.2001718.10
– volume: 8
  start-page: 536
  year: 2020
  ident: 2024102101461492000_56.2.2001718.3
  article-title: Tackling two pandemics: a plea on World Tuberculosis Day
  publication-title: Lancet Respir Med
  doi: 10.1016/S2213-2600(20)30151-X
– ident: 2024102101461492000_56.2.2001718.7
  doi: 10.1101/2020.04.28.20079582
– ident: 2024102101461492000_56.2.2001718.9
  doi: 10.1101/2020.03.19.20039107
– volume: 24
  start-page: 545
  year: 2020
  ident: 2024102101461492000_56.2.2001718.4
  article-title: Impact of COVID-19 on tuberculosis control in China
  publication-title: Int J Tuberc Lung Dis
  doi: 10.5588/ijtld.20.0127
– volume: 7
  start-page: e209
  year: 2019
  ident: 2024102101461492000_56.2.2001718.13
  article-title: Age-targeted tuberculosis vaccination in China and implications for vaccine development: a modelling study
  publication-title: Lancet Glob Health
  doi: 10.1016/S2214-109X(18)30452-2
– volume: 26
  start-page: 233
  year: 2020
  ident: 2024102101461492000_56.2.2001718.16
  article-title: Tuberculosis, COVID-19 and migrants: preliminary analysis of deaths occurring in 69 patients from two cohorts
  publication-title: Pulmonology
  doi: 10.1016/j.pulmoe.2020.05.002
– volume: 10
  start-page: e0132840
  year: 2015
  ident: 2024102101461492000_56.2.2001718.5
  article-title: Whole genome sequencing shows a low proportion of tuberculosis disease is attributable to known close contacts in rural Malawi
  publication-title: PloS One
  doi: 10.1371/journal.pone.0132840
– reference: 32703778 - Eur Respir J. 2020 Sep 24;56(3):2002710. doi: 10.1183/13993003.02710-2020.
SSID ssj0016431
Score 2.6625388
SecondaryResourceType review_article
Snippet Before the coronavirus disease 2019 (COVID-19) pandemic, over 4000 people were dying from tuberculosis (TB) every day [1]. As with past emergencies [2], the...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 2001718
SubjectTerms Agora
Antitubercular Agents - therapeutic use
Communicable Disease Control - organization & administration
Comorbidity
Coronavirus Infections - epidemiology
Coronavirus Infections - prevention & control
Cost of Illness
COVID-19
Female
Global Health
Humans
Incidence
Male
Pandemics - prevention & control
Pandemics - statistics & numerical data
Pneumonia, Viral - epidemiology
Pneumonia, Viral - prevention & control
Risk Assessment
Tuberculosis, Pulmonary - diagnosis
Tuberculosis, Pulmonary - drug therapy
Tuberculosis, Pulmonary - epidemiology
Title The potential impact of COVID-19-related disruption on tuberculosis burden
URI https://www.ncbi.nlm.nih.gov/pubmed/32513784
https://www.proquest.com/docview/2411106705
https://pubmed.ncbi.nlm.nih.gov/PMC7278504
Volume 56
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBAviDvlpiDxNlzS2I6dR1SYxqSChjq0tyi-RKsYyZQmLzzyyzl2Eict1cSQqqhK3CPH56t9fC6fEXqrtchhXRNYZRnDlCqGRR7NsRQytucxauOYmJZf4uMzenLOzieT36OspaaWM_Vrb13J_2gV7oFebZXsDTTrhcIN-A76hStoGK7_rOOrsrYJP5Y7wxc8Lr5-__wRzxPsKlXApNTrTdW0k4MNDjTSVKq5LC0ZiXR1DGMb1Ur1TvpqFIof98m58k6bbO0QspgdHq2LYniyqIzZXHRQ--Hd9t86RPU--8PlbIhK_exqb1btSPW-iGjIhPNORZvplpCO3LqdUsEEwiQMyXjObcnEO2xF4wnUEfiI_ZO7sCQTVp4VN3MNse3GsJb18fudJc4nHrotjyBpLyR1QlIr5Ba6HXGwv2xg_3SIRIHF5k5d7N-sY64CIe_39GTbuvlry7KbeTsyZVb30b1uDxJ8aAH1AE1M8RDdWXZZFo_QCSAg8LgKWlwFZR7s4ioYcBXAZ4yroMXVY3R29Gm1OMbdmRtYMcZqLBTPOFE8jzNGuZQZFSQ0MC5U65xrEYdc57ERJlecJrmJEqPjSHKhVGJDtOQJOijKwjxDQSJhLdCaG8UNlXGSwCCZecJFRjTLaT5FUT9WqeoI6e25KJfpNVqaonf-R1ctH8v1zd_0Skhh3rTBsKwwZbNJobNzS58Ysil62irFCyRg9BMu6BTxLXX5BpaTfftJsb5w3OywHRAspM9v1s0X6O7wd3qJDuqqMa_A2K3la4fGP5GAoYc
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+potential+impact+of+COVID-19-related+disruption+on+tuberculosis+burden&rft.jtitle=The+European+respiratory+journal&rft.au=McQuaid%2C+C.+Finn&rft.au=McCreesh%2C+Nicky&rft.au=Read%2C+Jonathan+M.&rft.au=Sumner%2C+Tom&rft.date=2020-08-01&rft.issn=0903-1936&rft.eissn=1399-3003&rft.volume=56&rft.issue=2&rft.spage=2001718&rft_id=info:doi/10.1183%2F13993003.01718-2020&rft.externalDBID=n%2Fa&rft.externalDocID=10_1183_13993003_01718_2020
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0903-1936&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0903-1936&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0903-1936&client=summon